Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan

Joint Authors

Cheng, Ken-Sheng
Lai, Hsiang-Chun
Chang, Chia-Hsi
Chen, Tsung-Wei
Feng, Chun-Lung
Chou, Jen-Wei

Source

Gastroenterology Research and Practice

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-8, 8 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-06-13

Country of Publication

Egypt

No. of Pages

8

Main Subjects

Diseases

Abstract EN

The incidence and prevalence of inflammatory bowel disease (IBD) are low but increasing in Taiwan.

We aimed to investigate the epidemiology and clinical outcomes of IBD in central Taiwan.

We retrospectively analyzed patients with IBD diagnosed at our hospital between January 2000 and September 2018.

The diagnostic criteria were based on endoscopic and pathologic findings.

Clinical characteristics, treatment regimens, and treatment outcomes were analyzed.

A total of 190 patients with IBD were enrolled (80 with Crohn’s disease (CD) and 110 with ulcerative colitis (UC)).

The mean age at diagnosis was 38.4 years (CD: 36 years, UC: 40 years).

Male patients accounted for the majority of patients (71.1%).

The male-to-female ratio was 3 : 1 for CD and 2.1 : 1 for UC.

Current and ever smokers accounted for 30.5% of all patients.

Only 4.2% of patients had a family history of IBD.

Extraintestinal manifestations (EIMs) were reported in 7.9%, and colorectal cancers (CRCs) were reported in 2.1% of all patients.

In patients with CD, the ileal type was the most common disease phenotype (57.5%), and the stricturing type was the most common disease behavior (60.0%).

In patients with UC, left-sided colitis was the predominant disease extent (42.7%).

The seroprevalence of hepatitis B virus (HBV) was 13.3%.

The incidence of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in patients with UC was 22%.

5-Aminosalicylic acids were the preferred treatment for UC, whereas corticosteroids, immunomodulators, and biologic agents were preferred for CD.

In patients with CD, the bowel resection rate was 38.8%, and the incidence of hip avascular necrosis was 3.8%.

In Taiwan, patients with IBD showed a male predominance, lack of familial clustering, a higher prevalence of HBV infection, and a lower prevalence of p-ANCA, EIMs, and CRC.

Moreover, a higher incidence of the ileal type with poor outcomes of CD and left-sided predominance in UC were found.

American Psychological Association (APA)

Chou, Jen-Wei& Lai, Hsiang-Chun& Chang, Chia-Hsi& Cheng, Ken-Sheng& Feng, Chun-Lung& Chen, Tsung-Wei. 2019. Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan. Gastroenterology Research and Practice،Vol. 2019, no. 2019, pp.1-8.
https://search.emarefa.net/detail/BIM-1155176

Modern Language Association (MLA)

Cheng, Ken-Sheng…[et al.]. Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan. Gastroenterology Research and Practice No. 2019 (2019), pp.1-8.
https://search.emarefa.net/detail/BIM-1155176

American Medical Association (AMA)

Chou, Jen-Wei& Lai, Hsiang-Chun& Chang, Chia-Hsi& Cheng, Ken-Sheng& Feng, Chun-Lung& Chen, Tsung-Wei. Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan. Gastroenterology Research and Practice. 2019. Vol. 2019, no. 2019, pp.1-8.
https://search.emarefa.net/detail/BIM-1155176

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1155176